Basic information Safety Supplier Related

CDDO-2-P-Im

Basic information Safety Supplier Related

CDDO-2-P-Im Basic information

Product Name:
CDDO-2-P-Im
Synonyms:
  • CDDO-2-P-Im
  • CPD1589
  • CPDB1589
  • CDDO-3P-Imidazolide
  • Oleana-1,9(11)-diene-2-carbonitrile, 3,12,28-trioxo-28-[4-(3-pyridinyl)-1H-imidazol-1-yl]-
  • CDDO 3P Im,CDDO3PIm
  • CDDO-3P-Im, 10 mM in DMSO
CAS:
1883650-95-0
MF:
C39H46N4O3
MW:
618.81
Mol File:
1883650-95-0.mol
More
Less

CDDO-2-P-Im Chemical Properties

Boiling point:
771.1±70.0 °C(Predicted)
Density 
1.25±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: 250 mg/mL (404.00 mM)
form 
Solid
pka
3.34±0.12(Predicted)
color 
White to off-white
More
Less

CDDO-2-P-Im Usage And Synthesis

Uses

CDDO-3P-Im is an analogue of CDDO-Imidazolide with chemopreventive effect. CDDO-3P-Im can reduce the size and the severity of the lung tumors in mouse lung cancer model[1]. CDDO-3P-Im is a orally active necroptosis inhibitor that can be used for the research of ischemia/reperfusion (I/R)[2].

in vivo

CDDO-3P-Im is more stable than CDDO-Im in pharmacokinetic studies[1].
CDDO-3P-Im significantly elevates heme oxygenase-1 (HO-1) and quinone reductase (NQO1) mRNA and protein levels in various mouse tissues in vivo[1].
CDDO-3P-Im (50-200 mg/kg; diet; for 16 weeks) decreases the number, the size and the severity of tumors in A/J mice[1].

Animal Model:Seven week-old female A/J mice[1]
Dosage:50 mg/kg, 200 mg/kg
Administration:Diet; for 16 weeks
Result:Decreased the number, the size and the severity of tumors.

References

[1] Cao M , et al. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention. Pharmacol Res. 2015 Oct;100:135-47. DOI:10.1016/j.phrs.2015.07.024
[2] Yuanyuan Wang, et al. Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. Eur J Med Chem. 2020 Nov 21;113030. DOI:10.1016/j.ejmech.2020.113030

CDDO-2-P-ImSupplier

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com